awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33451134-3C54849E-0D6A-4871-B5FC-5E6741AA0355
Q33451134-3C54849E-0D6A-4871-B5FC-5E6741AA0355
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33451134-3C54849E-0D6A-4871-B5FC-5E6741AA0355
Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients.
P2860
Q33451134-3C54849E-0D6A-4871-B5FC-5E6741AA0355
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33451134-3C54849E-0D6A-4871-B5FC-5E6741AA0355
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d24ee8bf80bf85ab3cd6427b445654f89b2c8a34
P2860
Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.